Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin
- 31 March 2011
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 54 (3) , 506-512
Abstract
No abstract availableKeywords
Funding Information
- NIH (1R01DK62277, 1R01CA124414)
- 1F30DK083235 (PEG157)
- Rango’s Fund for the Enhancement of Pathology Research
- Roche Pharmaceuticals
This publication has 38 references indexed in Scilit:
- Accelerated Liver Regeneration and Hepatocarcinogenesis in Mice Overexpressing Serine-45 Mutant β-CateninHepatology, 2010
- Unique phenotype of hepatocellular cancers with exon‐3 mutations in beta‐catenin gene†Hepatology, 2009
- Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel.2002
- RanBP3 influences interactions between CRM1 and its nuclear protein export substratesEMBO Reports, 2001
- Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6Current Biology, 2001
- LDL-receptor-related protein 6 is a receptor for Dickkopf proteinsNature, 2001
- Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosisThe Lancet, 2001
- Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of α‐interferon and oral tegafur/uracilJournal of Gastroenterology and Hepatology, 2000
- Interferon-induced gene expression and signaling in human hepatoma cell linesJournal of Hepatology, 2000
- β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus InfectionThe American Journal of Pathology, 1999